Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
MiR-124 could Inhibit CD151 Overexpression Associated with Non-Small Cell Lung Carcinoma Progression
Ke Li, Fengdi Hu, Chunxiang Luo and Jiangqiang Zhang
Research Article: J Oncol Res Treat
Treatment Options and Strategies of Somatostatinoma
Perspective: J Oncol Res Treat
DOI: 10.4172/aot.1000217
Melanoma Prevention: Protecting Skin from the Sun
Perspective: J Oncol Res Treat
DOI: 10.4172/aot.1000209
Advances in Sarcoma Research: New Treatment Options and Strategies
Opinion Article: J Oncol Res Treat
DOI: 10.4172/aot.1000210
Preventing Tumors: Lifestyle Changes and Screening Recommendations
Perspective: J Oncol Res Treat
DOI: 10.4172/aot.1000211
Alternative Cancer Treatments: Examining Targeted Therapy and Immunotherapy
Opinion Article: J Oncol Res Treat
DOI: 10.4172/aot.1000213
Fighting Esophageal Cancer: Prevention Strategies and Treatment Options
Commentry: J Oncol Res Treat
DOI: 10.4172/aot.1000216
Radiation Therapy for Prostate Cancer: Understanding Treatment Options
Commentary: J Oncol Res Treat
DOI: 10.4172/aot.1000214
Squamous Cell Carcinoma: Causes, Diagnosis, and Treatment
Short Communication: J Oncol Res Treat
DOI: 10.4172/aot.1000215
Biggest Challenges involved in the Treatment of Lymphoma
Perspective: J Oncol Res Treat
DOI: 10.4172/aot.1000212
Extra Medullary Solitary Plasmacytoma of the Oropharynx: A Case Report
Case Report: J Oncol Res Treat
Make the best use of Scientific Research and information from our 700 + peer reviewed, 黑料网 Journals